CA2889592A1 - Process for preparing bile acid derivatives - Google Patents

Process for preparing bile acid derivatives Download PDF

Info

Publication number
CA2889592A1
CA2889592A1 CA2889592A CA2889592A CA2889592A1 CA 2889592 A1 CA2889592 A1 CA 2889592A1 CA 2889592 A CA2889592 A CA 2889592A CA 2889592 A CA2889592 A CA 2889592A CA 2889592 A1 CA2889592 A1 CA 2889592A1
Authority
CA
Canada
Prior art keywords
compound
formula
pharmaceutically acceptable
preparing
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2889592A
Other languages
English (en)
French (fr)
Inventor
Roberto Pellicciari
Antimo GIOIELLO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intercept Pharmaceuticals Inc
Original Assignee
Intercept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals Inc filed Critical Intercept Pharmaceuticals Inc
Publication of CA2889592A1 publication Critical patent/CA2889592A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA2889592A 2012-10-26 2013-10-25 Process for preparing bile acid derivatives Abandoned CA2889592A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718966P 2012-10-26 2012-10-26
US61/718,966 2012-10-26
PCT/US2013/066917 WO2014066819A1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Publications (1)

Publication Number Publication Date
CA2889592A1 true CA2889592A1 (en) 2014-05-01

Family

ID=50545344

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2889592A Abandoned CA2889592A1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Country Status (22)

Country Link
US (2) US9777038B2 (OSRAM)
EP (1) EP2912013B1 (OSRAM)
JP (1) JP6272888B2 (OSRAM)
KR (1) KR102068381B1 (OSRAM)
CN (2) CN108250264A (OSRAM)
AU (1) AU2013334122B2 (OSRAM)
BR (1) BR112015009395A2 (OSRAM)
CA (1) CA2889592A1 (OSRAM)
CY (1) CY1119731T1 (OSRAM)
DK (1) DK2912013T3 (OSRAM)
ES (1) ES2655034T3 (OSRAM)
HK (1) HK1253301A1 (OSRAM)
HU (1) HUE036887T2 (OSRAM)
IL (1) IL238454B (OSRAM)
MX (1) MX361653B (OSRAM)
NO (1) NO2968302T3 (OSRAM)
NZ (2) NZ745013A (OSRAM)
PL (1) PL2912013T3 (OSRAM)
PT (1) PT2912013T (OSRAM)
SG (1) SG11201503247UA (OSRAM)
SM (1) SMT201700602T1 (OSRAM)
WO (1) WO2014066819A1 (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108250264A (zh) 2012-10-26 2018-07-06 英特塞普特医药品公司 制备胆汁酸衍生物的方法
LT3149019T (lt) 2014-05-29 2020-02-25 Bar Pharmaceuticals S.R.L. Cholano dariniai, skirti naudoti fxr ir tgr5/gpbar1 medijuojamų ligų gydymui ir (arba) prevencijai
EA033445B1 (ru) 2014-11-19 2019-10-31 Nzp Uk Ltd 5-бета-6-алкил-7-гидрокси-3-оновые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr
WO2016079517A1 (en) 2014-11-19 2016-05-26 Dextra Laboratories Limited 6-alkyl-7-hydroxy-4-en-3-one steroids as intermediates for the production of steroidal fxr modulators
EA033603B1 (ru) 2014-11-19 2019-11-08 Nzp Uk Ltd 6-альфа-алкил-6,7-дионовые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr
WO2016079519A1 (en) 2014-11-19 2016-05-26 Dextra Laboratories Limited 6.alpha.-alkyl-3,7-dione steroids as intermediates for the production of steroidal fxr modulators
CN104672290B (zh) * 2015-01-05 2017-06-06 北京普禄德医药科技有限公司 一种用于预防或治疗fxr‑介导的疾病的药物及其制备方法和用途
EA036404B1 (ru) 2015-02-06 2020-11-06 Интерсепт Фармасьютикалз, Инк. Фармацевтические композиции для комбинированной терапии
KR20180052756A (ko) * 2015-09-24 2018-05-18 인터셉트 파마슈티컬즈, 인크. 담즙산 유도체 제조를 위한 방법 및 중간체
WO2017079062A1 (en) * 2015-11-06 2017-05-11 Intercept Pharmaceuticals, Inc. Methods for the preparation of obeticholic acid and derivatives thereof
US20200262865A1 (en) * 2016-02-15 2020-08-20 Alexander Khoruts Compositions and methods for treating clostridium associated diseases
KR102377338B1 (ko) 2016-04-13 2022-03-21 인터셉트 파마슈티컬즈, 인크. 암의 치료 방법
TW201738254A (zh) * 2016-04-19 2017-11-01 英特賽普醫藥品公司 奧貝膽酸及其衍生物之製備方法
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
BR112019006242A2 (pt) * 2016-09-30 2019-06-18 Intercept Pharmaceuticals Inc formas cristalinas de um derivado de ácido biliar
AU2018307611A1 (en) 2017-07-24 2020-02-06 Intercept Pharmaceuticals, Inc. Isotopically labeled bile acid derivatives
EP3660030A4 (en) * 2017-07-26 2021-04-21 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. METHOD OF MANUFACTURING STEROID-DERIVATIVE FXR AGONISTS
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
CA3142358A1 (en) 2019-05-30 2020-12-03 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists
TW202140440A (zh) 2020-02-28 2021-11-01 美商克力歐普股份有限公司 Gpr40激動劑
EP4153589A4 (en) 2020-05-19 2024-06-12 Kallyope, Inc. AMPK ACTIVATORS
WO2021263039A1 (en) 2020-06-26 2021-12-30 Kallyope, Inc. Ampk activators
JP7583398B2 (ja) 2020-09-18 2024-11-14 ソウル大学校産学協力団 タウロデオキシコール酸ナトリウムの大量生産方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216015A (en) * 1991-02-05 1993-06-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having hypocholesterolemic properties
DE60205891T2 (de) 2001-03-12 2006-06-22 Intercept Pharmaceuticals, Inc. Steroide als agonisten für fxr
EP1568706A1 (en) 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
PL2040713T3 (pl) * 2006-06-27 2014-11-28 Intercept Pharmaceuticals Inc Pochodne kwasów żółciowych jako ligandy FXR do zapobiegania lub leczenia chorób lub stanów, w których pośredniczy FXR
EP2303026B1 (en) * 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US8796249B2 (en) * 2008-07-30 2014-08-05 Intercept Pharmaceuticals, Inc. TGR5 modulators and methods of use thereof
ES2774368T3 (es) * 2008-11-19 2020-07-20 Intercept Pharmaceuticals Inc Moduladores de TGR5 y métodos de uso de los mismos
CN108250264A (zh) 2012-10-26 2018-07-06 英特塞普特医药品公司 制备胆汁酸衍生物的方法

Also Published As

Publication number Publication date
ES2655034T3 (es) 2018-02-16
HK1253301A1 (zh) 2019-06-14
BR112015009395A2 (pt) 2017-07-04
SG11201503247UA (en) 2015-06-29
NO2968302T3 (OSRAM) 2018-02-03
AU2013334122A1 (en) 2015-05-14
MX361653B (es) 2018-12-13
NZ707389A (en) 2018-08-31
HK1214239A1 (zh) 2016-07-22
HUE036887T2 (hu) 2018-08-28
DK2912013T3 (en) 2018-01-15
US20180079776A1 (en) 2018-03-22
CN105102425A (zh) 2015-11-25
AU2013334122B2 (en) 2017-11-02
KR20150074062A (ko) 2015-07-01
EP2912013A4 (en) 2016-06-01
PL2912013T3 (pl) 2018-05-30
US10202414B2 (en) 2019-02-12
SMT201700602T1 (it) 2018-03-08
IL238454A0 (en) 2015-06-30
KR102068381B1 (ko) 2020-01-20
WO2014066819A1 (en) 2014-05-01
US9777038B2 (en) 2017-10-03
PT2912013T (pt) 2018-01-03
CN108250264A (zh) 2018-07-06
US20150291653A1 (en) 2015-10-15
CY1119731T1 (el) 2018-06-27
JP2015533852A (ja) 2015-11-26
EP2912013A1 (en) 2015-09-02
JP6272888B2 (ja) 2018-01-31
CN105102425B (zh) 2018-04-10
MX2015005286A (es) 2015-10-29
EP2912013B1 (en) 2017-10-11
IL238454B (en) 2018-11-29
NZ745013A (en) 2019-08-30

Similar Documents

Publication Publication Date Title
CA2889592A1 (en) Process for preparing bile acid derivatives
KR100555970B1 (ko) 2-아미노-1,3-프로판디올유도체의 제조방법
RU2624007C2 (ru) Способ получения улипристала ацетата и его промежуточных продуктов
PL200165B1 (pl) Sposób wytwarzania estrów nitroksyalkilowych naproksenu oraz ester nitroksybutylowy kwasu 2-(S)-(6-metoksy-2-naftylo)propanowego o wysokim nadmiarze enancjomerycznym
PL130559B1 (en) Process for preparing pure isosorbite 5-nitrate
US3538120A (en) Cyclopentyl-alkanoic acids
KR20090066910A (ko) L-3-o-치환-아스코르브산의 개선된 제조방법
CN110551133A (zh) 叔丁基-5-(羟甲基)-7-氧杂-2-氮杂螺[3.5]壬烷-2-甲酸基酯的制法
DK170233B1 (da) Fremgangsmåde til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
EP0243646B1 (en) A process for the preparation of forskolin from 9-deoxy-forskolin and intermediates used therein
AU2006272420A1 (en) Method for producing nebivolol
CN109134577B (zh) 一种3α-羟基-5α-胆烷酸的合成方法
US5072008A (en) Manufacture of lactol derivatives
PL243187B1 (pl) Sposób i związki pośrednie do otrzymywania menachinonu MK-7
HK1214239B (en) Process for preparing bile acid derivatives
US4906759A (en) Process for the production of 4-alkoxy-2(5H) thiophenones
Beccalli et al. 4-Azidotetronic Acids: A New Class of Azido Derivatives
JP2005314260A (ja) フラボンc配糖体の製法
CN101575287B (zh) 一种辛伐他汀铵盐的合成方法及所用中间体及其制备方法
Yamagata et al. Rhodium (II) acetate‐catalyzed reaction of 2‐amino‐4, 5‐dihydro‐3‐furancarbonitriles with dialkyl diazomalonates
Ye et al. Expedient Construction of the Ziegler Intermediate Useful for the Synthesis of Forskolin via Consecutive Rearrangements
JPH03246264A (ja) 2―アミノペンタン酸化合物の新規な製造法
CN102690254A (zh) 辛伐他汀铵盐中间体及其制备方法
PL197215B1 (pl) Nowy chiralny bromospirolakton karanu i sposób jego wytwarzania
KR20060094553A (ko) 2',2'-디플루오로뉴글레오시드 중간체의 제조방법

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180705

FZDE Discontinued

Effective date: 20220502

FZDE Discontinued

Effective date: 20220502